Status
Conditions
Treatments
About
OPTIMAL-HF is a pragmatic, cluster randomized, single-blind intervention trial that will be conducted at an outpatient clinic in Argentina. The trial will assess the effectiveness of an individualized-based alert system compared to usual care in improving GDMT optimization at 90 days in patients with HFrEF.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Patients
Inclusion Criteria:
Exclusion Criteria:
Cardiologist
Inclusion criteria:
Cardiologists from an outpatient clinic at a cardiovascular center in Buenos Aires will be selected for potential participation in the study.
Exclusion criteria Cardiologists belonging to the heart failure service
Primary purpose
Allocation
Interventional model
Masking
240 participants in 2 patient groups
Loading...
Central trial contact
Lucrecia Burgos, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal